Roche to temporarily halt Tamiflu shipments to U.S.

Share this article:
Swiss pharma company Roche said today it has temporarily suspended shipments of the anti-viral drug Tamiflu to wholesalers and other private recipients in the U.S. to make sure enough treatments will be available to treat conventional cases of the flu this winter.
Roche said companies have been creating their own stockpiles for use by their employees in the event of a pandemic caused by avian flu.
"At the present time we do not have an avian influenza pandemic in the United States," George Abercrombie, president of the Roche's American subsidiary, said in a statement yesterday. "However, we need to make sure that people exposed to this year's seasonal flu virus will have access to Tamiflu."
Roche said it would resume shipments of the drug when more flu cases occur this winter.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.